ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 101 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,109,681 | +25.6% | 439,517 | +96.6% | 0.00% | – |
| Q2 2023 | $1,679,108 | +50.6% | 223,583 | -9.4% | 0.00% | – |
| Q1 2023 | $1,115,002 | -33.1% | 246,682 | +66.7% | 0.00% | – |
| Q4 2022 | $1,667,385 | -37.9% | 147,949 | -47.3% | 0.00% | -100.0% |
| Q3 2022 | $2,686,000 | +98.5% | 280,586 | +67.8% | 0.00% | – |
| Q2 2022 | $1,353,000 | -45.4% | 167,255 | +14.1% | 0.00% | – |
| Q1 2022 | $2,478,000 | +14.8% | 146,630 | +46.1% | 0.00% | – |
| Q4 2021 | $2,158,000 | -75.3% | 100,374 | -15.2% | 0.00% | -100.0% |
| Q3 2021 | $8,747,000 | +257.6% | 118,419 | +164.7% | 0.00% | – |
| Q2 2021 | $2,446,000 | -61.4% | 44,736 | -48.0% | 0.00% | -100.0% |
| Q1 2021 | $6,343,000 | -74.0% | 86,013 | -69.6% | 0.00% | -83.3% |
| Q4 2020 | $24,417,000 | – | 283,256 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $46,559,640 | 13.20% |
| Vivo Capital, LLC | 4,220,048 | $20,256,230 | 2.22% |
| Logos Global Management LP | 1,000,000 | $4,800,000 | 0.64% |
| Orbimed Advisors | 2,871,000 | $13,780,800 | 0.29% |
| Redmile Group, LLC | 1,283,289 | $6,159,787 | 0.29% |
| BRAIDWELL LP | 1,249,900 | $5,999,520 | 0.19% |
| Cormorant Asset Management, LP | 612,079 | $2,937,979 | 0.17% |
| Nan Fung Group Holdings Ltd | 41,950 | $201,360 | 0.16% |
| Forefront Analytics, LLC | 13,769 | $66,092 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 35,071 | $168,341 | 0.03% |